CYTARAbine for Injection USP, lyophiled in glass vials, 1 gram per vial, Rx only, Distributed by Bedford Laboratories, Bedford, OH 44146, Manufactured by Ben Venue Labs, Inc., Bedford, OH 44146, NDC 55390-808-01
Published August 27, 2014 · Recall initiated: July 31, 2014
Summary
FDA records drug Class II recall D-1543-2014, published August 27, 2014 and initiated July 31, 2014. Recalling firm: Ben Venue Laboratories Inc; Status: Terminated; Reported quantity: 7172 vials; Lot: Lot # 0161-13-2167551; Exp. 07/14 Lot # 0161-13-2176919; Exp. 08/14. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: Crimp defects during visual inspection could affect container closure integrity.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Ben Venue Laboratories Inc
- Distributor
- Nationwide
- Lot
- Lot # 0161-13-2167551; Exp. 07/14 Lot # 0161-13-2176919; Exp. 08/14
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAProSol - sulfite-free (Amino Acid) Injection, 20%, 2000 mL VIAFLEX container bag, Rx only, Baxter HealthcareAugust 27, 2014
- FDATriveen - PRx RNF Capsules, 30-count bottles, Rx only; Manufactured for: Trigen Laboratories, Inc.,August 27, 2014
- FDAAcetylcysteine Solution, USP, 10%, 30 mL vial, Rx only, Ben Venue Laboratories, Inc., Bedford, OH, NDCMay 28, 2014
- FDALeucovorin Calcium Injection USP, single use vials, 10mg/mL; 50mL, Rx only, Manufactured by: Ben Venue Labs,November 7, 2012
- FDAVecuronium Bromide for Injection, For IV use only, 20 mg per vial, 10 x 10 mg Vials, lyophilized powder perOctober 3, 2012
- FDAOctreotide Acetate Injection, 50 mcg/mL (0.05 mg/mL), 1 mL single dose vials, packaged in 10 x 1 mL singleJune 20, 2012
Questions about this recall
Was CYTARAbine for Injection USP, lyophiled in glass vials, 1 gram per vial, Rx only, Distributed by Bedford Laboratories, Bedford, OH 44146, Manufactured by Ben Venue Labs, Inc., Bedford, OH 44146, NDC 55390-808-01 recalled?
Yes. FDA published recall D-1543-2014 on August 27, 2014. Reported hazard: Lack of Assurance of Sterility: Crimp defects during visual inspection could affect container closure integrity.
What should I do if I have this product?
Voluntary: Firm initiated · Letter